메뉴 건너뛰기




Volumn 24, Issue 3, 1997, Pages 498-505

Sulbactam/cefoperazone versus cefotaxime for the treatment of moderate- to-severe bacterial infections: Results of a randomized, controlled clinical trial

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ENZYME; BETA LACTAMASE; BETA LACTAMASE INHIBITOR; CEFOPERAZONE; CEFOTAXIME; CEPHALOSPORIN DERIVATIVE; SULBACTAM; SULPERAZON;

EID: 0031028898     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinids/24.3.498     Document Type: Article
Times cited : (17)

References (12)
  • 1
    • 0022395896 scopus 로고
    • The cefoperazone-sulbactam combination. in vitro qualities including β-lactamase stability, antimicrobial activity, and interpretive criteria for disk diffusion tests
    • Jones RN, Barry AL, Thornsberry C, Wilson HW. The cefoperazone-sulbactam combination. In vitro qualities including β-lactamase stability, antimicrobial activity, and interpretive criteria for disk diffusion tests. Am J Clin Pathol 1985;84:496-505.
    • (1985) Am J Clin Pathol , vol.84 , pp. 496-505
    • Jones, R.N.1    Barry, A.L.2    Thornsberry, C.3    Wilson, H.W.4
  • 2
    • 0018143694 scopus 로고
    • CP-45,899, a β-lactamase inhibitor that extends the antibacterial spectrum of β-lactams: Initial bacteriological characterization
    • English AR, Retsema JA, Girard AE, Lynch JE, Barth WE. CP-45,899, a β-lactamase inhibitor that extends the antibacterial spectrum of β-lactams: initial bacteriological characterization. Antimicrob Agents Chemother 1978;14:414-9.
    • (1978) Antimicrob Agents Chemother , vol.14 , pp. 414-419
    • English, A.R.1    Retsema, J.A.2    Girard, A.E.3    Lynch, J.E.4    Barth, W.E.5
  • 3
    • 0345473750 scopus 로고
    • Cefoperazone: A review of its antimicrobial spectrum, β-lactamase stability, enzyme inhibition, and other in vitro characteristics
    • Jones RN, Barry AL. Cefoperazone: a review of its antimicrobial spectrum, β-lactamase stability, enzyme inhibition, and other in vitro characteristics. Rev Infect Dis 1983;5 (suppl):S108-26.
    • (1983) Rev Infect Dis , vol.5 , Issue.SUPPL.
    • Jones, R.N.1    Barry, A.L.2
  • 4
    • 0025130207 scopus 로고
    • In vitro activities of cefoperazone and sulbactam singly and in combination against cefoperazone-resistant members of the family Enterobacteriaceae and nonfermenters
    • Fass RJ, Gregory WW, D'Amato RF, Matsen JM, Wright DN, Young LS. In vitro activities of cefoperazone and sulbactam singly and in combination against cefoperazone-resistant members of the family Enterobacteriaceae and nonfermenters. Antimicrob Agents Chemother 1990;34:2256-9.
    • (1990) Antimicrob Agents Chemother , vol.34 , pp. 2256-2259
    • Fass, R.J.1    Gregory, W.W.2    D'Amato, R.F.3    Matsen, J.M.4    Wright, D.N.5    Young, L.S.6
  • 5
    • 0025025090 scopus 로고
    • In vitro activities of ampicillin-sulbactam and cefoperazone-sulbactam against oxacillin-susceptible and oxacillin-resistant staphylococci
    • Barry AL, Jones RN. In vitro activities of ampicillin-sulbactam and cefoperazone-sulbactam against oxacillin-susceptible and oxacillin-resistant staphylococci. Antimicrob Agents Chemother 1990;34:1830-2.
    • (1990) Antimicrob Agents Chemother , vol.34 , pp. 1830-1832
    • Barry, A.L.1    Jones, R.N.2
  • 6
    • 0026565569 scopus 로고
    • Multicentre study on antibiotic susceptibilities of anaerobic bacteria to cefoperazone-sulbactam and other antimicrobial agents
    • Clark RB, Bartelt MA, Chan EL, Dalton HP. Multicentre study on antibiotic susceptibilities of anaerobic bacteria to cefoperazone-sulbactam and other antimicrobial agents. J Antimicrob Chemother 1992;29:57-67.
    • (1992) J Antimicrob Chemother , vol.29 , pp. 57-67
    • Clark, R.B.1    Bartelt, M.A.2    Chan, E.L.3    Dalton, H.P.4
  • 7
    • 0020438088 scopus 로고
    • Activity of cefoperazone and two β-lactamase inhibitors, sulbactam and clavulanic acid, against Bacteroides spp. correlated with β-lactamase production
    • Crosby MA, Gump DW. Activity of cefoperazone and two β-lactamase inhibitors, sulbactam and clavulanic acid, against Bacteroides spp. correlated with β-lactamase production. Antimicrob Agents Chemother 1982;22:398-405.
    • (1982) Antimicrob Agents Chemother , vol.22 , pp. 398-405
    • Ma, C.1    Gump, D.W.2
  • 8
    • 0021981410 scopus 로고
    • Well controlled comparative clinical trial of sulbactam/cefopcrazone (SBT/CPZ) and cefotaxime (CTX) in the treatment of respiratory infections
    • Hara K, Saito A, Suzuyama Y, et al. Well controlled comparative clinical trial of sulbactam/cefopcrazone (SBT/CPZ) and cefotaxime (CTX) in the treatment of respiratory infections. Chemotherapy 1985;33:184-8.
    • (1985) Chemotherapy , vol.33 , pp. 184-188
    • Hara, K.1    Saito, A.2    Suzuyama, Y.3
  • 9
    • 0021275386 scopus 로고
    • Significance of combination of sulbactam and cefoperazone in the treatment of complicated urinary tract infection
    • Kawada Y, Kanematsu M, Nishiura T, et al. Significance of combination of sulbactam and cefoperazone in the treatment of complicated urinary tract infection. Chemotherapy 1984;32 (suppl 4):625-6.
    • (1984) Chemotherapy , vol.32 , Issue.SUPPL. 4 , pp. 625-626
    • Kawada, Y.1    Kanematsu, M.2    Nishiura, T.3
  • 10
    • 0025248077 scopus 로고
    • A randomized clinical study of cefoperazone and sulbactam versus gentamicin and clindamycin in the treatment of intra-abdominal infections
    • Jauregui LE, Appelbaum PC, Fabian TC, et al. A randomized clinical study of cefoperazone and sulbactam versus gentamicin and clindamycin in the treatment of intra-abdominal infections. J Antimicrob Chemother 1990;25:423-33.
    • (1990) J Antimicrob Chemother , vol.25 , pp. 423-433
    • Jauregui, L.E.1    Appelbaum, P.C.2    Fabian, T.C.3
  • 11
    • 0025738294 scopus 로고
    • Clinical experience with cefoperazone/sulbactam in critical surgical infection
    • Engin A, Mentes B, Turet S. Clinical experience with cefoperazone/sulbactam in critical surgical infection. Curr Ther Res 1991;49:989-97.
    • (1991) Curr Ther Res , vol.49 , pp. 989-997
    • Engin, A.1    Mentes, B.2    Turet, S.3
  • 12
    • 0023640807 scopus 로고
    • Effect of β-lactamase inhibitors on the antimicrobial activity of cefoperazone, cefotaxime, and ceftizoxime against aerobic and anaerobic β-lactamase producing bacteria
    • Fuchs PC, Jones RN, Barry AL. Effect of β-lactamase inhibitors on the antimicrobial activity of cefoperazone, cefotaxime, and ceftizoxime against aerobic and anaerobic β-lactamase producing bacteria. Diagn Microbiol Infect Dis 1987;8:61-5.
    • (1987) Diagn Microbiol Infect Dis , vol.8 , pp. 61-65
    • Fuchs, P.C.1    Jones, R.N.2    Barry, A.L.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.